May 13, 2020 / 12:16 PM / 2 months ago

BRIEF-BeyondSpring Granted New U.S. Patent For Plinabulin To Treat Severe Chemotherapy-Induced Neutropenia From Taxane In Cancer Patients

May 13 (Reuters) - Beyondspring Inc:

* BEYONDSPRING GRANTED NEW U.S. PATENT FOR PLINABULIN TO TREAT SEVERE CHEMOTHERAPY-INDUCED NEUTROPENIA FROM TAXANE IN CANCER PATIENTS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below